Skip to main content
Signal8

Horvath Susan

SEC insider (Form 3/4/5 filer). CIK 0001322846. V.P. of Finance & CFO at Panbela Therapeutics, Inc. (PBLA). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 1, 2024. Located in WACONIA, MN.

Companies Horvath Susan has filed insider reports for

  • Panbela Therapeutics, Inc. (PBLA): Officer, V.P. of Finance & CFO
Horvath Susan profile photo

Horvath Susan

CIK: 0001322846

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Panbela Therapeutics, Inc. logo
PBLA

Panbela Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Panbela Therapeutics, Inc. logo
    PBLA

    Panbela Therapeutics, Inc.

    Oct 1, 2024
    Award

    Stock Option (right to buy)

    Direct
    25.5K shares-

1-1 of 1